SCHEMBL6495

SCHEMBL6495

Cc1noc(-c2ccc(Br)cc2)c1C(=O)COCCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.38
LPAR1 Q92633 3/20 0.37
PTGS1 P23219 1/20 0.37
LPAR3 Q9UBY5 2/20 0.36
POLB P06746 2/20 0.35
ALDH1A1 P00352 2/20 0.35
PKM P14618 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
TRPA1 O75762 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LPAR2 Q9HBW0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1624 0.89 AR (0.40) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL1463 0.83 TSHR (0.47) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL18597795 0.78 LPAR1 (0.50) TSHRRAB9ASMN1; SMN2L3MBTL1LPAR1
SCHEMBL2611 0.78 LPAR1 (0.50) TSHRRAB9ASMN1; SMN2L3MBTL1LPAR1
SCHEMBL1229 0.78 LPAR1 (0.35) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL1804 0.78 LPAR1 (0.35) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL1059 0.78 LPAR1 (0.35) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL7158 0.78 TSHR (0.58) TSHRRAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL1932 0.78 PKM (0.44) TSHRLMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL6671 0.77 MMP1 (0.39) TSHRLMNARAB9ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed